Making miniature machines - with Hamilton Smith

nature video
11 followers
Sep 5, 2023
Noy Bassik draws inspiration from origami to engineer miniature tools that he envisages as the surgeons of the future. Hamilton Smith is also in the business of making things. Working with Craig Venter, he recently created a bacterial cell controlled by a synthetic genome. As Hamilton and Noy talk, they offer insight into the overlapping worlds of biology and engineering.
I'm always amazed by how scientists and engineers outsmart the natural world.
One thing that may happen is that you're targeted to a specific goal,
but you may end up doing something else.
So if you observe something that looks promising, you have to be able to take it.
Hamilton Smith's initial work that led to the Nobel Prize was restriction enzymes.
And that allowed manipulation of DNA,
which opened up a whole new field of cutting and cloning and analyzing DNA,
and sequencing DNA, being able to take an organism and say, what's its blueprint?
That's an entirely new way of thinking and led to the Human Genome Project.
I wanted to ask you a little about the recent paper that's just been published online
with Craig Venter about the synthetic cell.
So this was a large technical challenge, it seems, to just make the DNA of this size.
Yeah, it's a technical achievement.
There will be a lot of science coming out of the applications of what we've done,
but right now it's a technical achievement to put together 1.1 million base pairs correctly,
from starting with just a sequence and synthesize with four chemicals, A, G, C, and T.
We're here today to announce the first synthetic cell.
A cell made by starting with the digital code in the computer,
building the chromosome from four bottles of chemicals,
assembling that chromosome in yeast, transplanting it into a recipient bacterial cell,
and transforming that cell into a new bacterial species.
This is the first self-replicating species that we've had on the planet whose parent is a computer.
So would it be fair to say that you downloaded the genetic code
and printed it on a very expensive printer to make a big molecule
and plugged it into the cell and then booted it up?
Yeah, that's right.
Craig likes to say that we've been sequencing genomes, now we're writing them.
Wow.
So for individuals that might be worried that you're creating a new bacteria
that has new and different properties, what would you say about that?
I would say not to worry.
Well, what we've done now is simply to make some minor changes in an existing organism.
It's not dangerous to humans, we can work in the laboratory quite safely with it.
It's also a very delicate organism.
If I put some out in the grass here, it would die.
It only lives in goats.
So goats should be worried, but not me.
Yeah.
Not even them so much.
And they shouldn't be worried because we can treat it.
Yeah.
How did you come about with the idea of building a synthetic cell?
Was it just to strip it down, or did you want to create more complex structures as well,
or did you want to make a factory to make biofuels one day?
I think once we have a minimal cell, we'll want to start adding different things to it
to make it a more complex cell.
For example, a pathway that would make a useful fuel or a pharmaceutical product or whatever.
He was interested very much in what I've been doing with synthetic cells,
I think partly because he's trying to see how it might be helpful in his own work.
What motivates us is almost the science fiction of autonomous medical tools.
Feynman talked about surgical micro-robots that you could swallow the surgeon,
and it would make decisions and cut out a cancer, things like that.
So we're trying to demonstrate some of the tools that may be useful to build some of these things.
So we build little micro-grippers that are about a millimeter in diameter that start out flat,
and then when we want them to be triggered, they can trigger and grab something,
and we've shown we can do little in vitro biopsies.
So these are very small robotic things that would be attached to a very thin wire.
Well, that's what makes them very interesting. They're tetherless.
Oh, really?
Yeah. And this gets into some of the long-term challenges in making these sorts of things.
We need them to either carry their energy on board
or be able to extract energy from the environment in order to actuate.
So the beautiful part is they're tetherless, and we build them out of thin metal films and polymers.
We can build nickel into them, and nickel is magnetic,
and so we can control them outside with a magnet and move them around where we want.
So I can bring it over to a place, and then via a trigger, I can actuate it.
And what I've been leading is trying to get them to respond to biochemicals, to use biochemical interactions.
Before, we had to use heat or nasty solvents like acetone or acids or things like that to trigger them,
to make this polymer change its properties.
And what I've just submitted for publication, what I've shown, is that I can get them to respond to enzymes.
If we can get it incredibly selective to, say, a disease marker, I think one of our dreams is maybe we...
Then it could sense and move towards that thing. Once it found it, it would start operating.
Absolutely.
Yeah. So that's really, it's getting incredible, I think.
It's pretty, you know, we just, I work on it for months,
and you kind of lose sight of the fact that you're really working on something weird.
With his latest work, it's a real technological feat.
These are not questions that seek to answer the fundamental nature of the universe
or whether things may be possible or not, but really about, you know,
if we want to do something, how do we go about doing it?
And that relates to my work, because we have this science fiction dream that we want to turn into a reality.
So I've often thought of what I do as falling into one of two slots.
There's the type of scientists or engineers that seek to understand things,
and those that seek to build things.
And it's a very different way of thinking in the lab, and it sounds like you're doing a bit of both.
It's a little bit of both. I don't know what would be a good analogy.
I always think of a car engine, I guess.
If you could take it apart and put it together,
I think you'd get a better understanding than just opening the hood.
Yeah, my parents tell me that was my childhood story of taking things apart and putting them together.
The difference, I always had parts left over, so I don't know what that means.
Yeah, that's a problem.
Yeah, but things still worked, so I guess they were non-essential.
Well, there you are. You're leaving out non-essential parts.
You're already playing the game.
Yeah, but I don't think I should be a surgeon. That may not be the way to go.
Feynman says, you know, what we cannot create, we cannot understand.
So, you know, we're taking that lesson.
We're still at the stage of fully understanding what nature has produced at the cell level.
And we're starting really with the simplest bacteria.
Just like early molecular biologists started with the very simplest viruses to study.
We thought that if we go to a very small cell with a small genome,
first of all, the genome is small enough that we could probably synthesize it.
And then at some point we could use our synthetic cell approach to build,
synthetically build a genome that's even smaller,
where we specifically leave out the genes that are not essential for growth in the laboratory.
They might be essential for the growth in the environment,
but under specific conditions in the laboratory, you can dispense with a lot of things.
So taking the air conditioning out of the car and seeing how little you can drive around.
Yeah, so we want to get down really just to the very basic machinery of the cell.
So one thing I was thinking of is with the miniaturized tools that our lab is developing,
right now they're metals and polymers.
But being able to integrate a living factory on it.
If I could use the tool to guide itself to a site where there's disease
and then have an engineered cell or an engineered factory to produce antibiotics
or anti-cancer agents and turn it on just when I want.
For example, a toxin against a specific cancer.
Absolutely.
It could be transported that way.
And that way you wouldn't be giving the toxin, the chemotherapy agent systemically
and there'd be less side effects and you might be able to deliver it into a difficult area
like deep inside the liver.
Do you think that's something that one day, a technical challenge,
we can put together the right parts?
Keep working on it.
Okay.
It's something I'll keep thinking about.
It's very exciting, yeah.
I think some of what Hamilton Smith does is similar to what I do.
I dream of a system.
I say, oh, this should be easy, and in reality we find out it's difficult
and we have one technical challenge after another,
but it's exploring the unknown with a final goal of building something.
I work in a very interdisciplinary lab.
We have chemists and physicists and engineers and electronics people,
and everyone has a different point of view.
We get to a group meeting, and by the time the electrical engineer asks the chemist
to explain their reaction, the chemist thinks of something new
and goes back downstairs and tries it out.
Yeah, that's good.
I think one of the most important things is to let students conceive of their own ideas
and be able to pursue them rather than being told to do something.
Can I ask, would you consider yourself an engineer in practical terms
and how you are building a synthetic cell?
This is engineering.
I'm glad to hear that.
As an engineer who works in…
You're in the right field.
Well, that's a fantastic thing to hear from you.
I think it's very important that engineers are included in worldwide scientific conferences
and events like the Lindau meeting,
and I'm very proud that there are few engineers like myself here
because I feel that we really contribute to the development of science.
We really see everything as a problem to be taken apart and put back together and solved,
and if you get us engineers excited about something, we just love to play.
Everything he's doing is new to me.
I had no idea that people were working on this.
It's very interesting talking to him.
